VIM and hepatocellular carcinoma: Many studies have shown VIM to be substantially expressed in liver metastases of pancreatic tumours [21], and expression is associated with increased invasiveness and metastasis potential for epithelial breast carcinoma [22], hepatocellular carcinoma [23] and cervical carcinoma [24].